Answers are grounded in this paper and cite their sources.
Care integration for patients with lifelong conditions requires successful transitions at key, high-risk times. For conditions diagnosed and traditionally managed within paediatric subspecialties, such as congenital heart disease (CHD), the period from adolescence into adulthood represents such a transition. During this important time of growth, young adults are asked to gain independence in managing their own healthcare. Failure to maintain care during transitional periods can result in a loss to follow-up and missed opportunities for secondary prevention, generating downstream complications with excess morbidity for patients. For children with CHD, procedures early in life are often palliative as opposed to curative, necessitating future interventions to ensure optimal outcomes for patients. Even many of the simple CHD lesions that can be treated with procedures that are considered ‘curative’ in childhood are increasingly being found to carry an increased risk of the development of comorbid cardiac conditions, especially arrhythmia and heart failure, in adulthood at relatively younger ages than individuals without CHD. If patients fall behind on diagnostic testing, chronic therapies, and medical team guidance, then outcomes are readily compromised. Most importantly, this failure leads to impaired functional, mental, and social well-being of the patients and their families, while also driving up resource utilization and creating challenges for the broader healthcare system. Heightened focus on the importance of care transition in CHD is not new. The first official guidance from the American Heart Association (AHA) on best practice in managing the transition to adult care for children with CHD was published in 2011. Following that initial scientific statement, a growing body of literature examining the transition process emerged, revealing that lapses in care occur in upwards of 40% of patients with CHD, most commonly during the period of adolescence when patients should be undergoing the transition process.1 Furthermore, these lapses in care result in increased healthcare costs with overall worse health outcomes. In 2022, the AHA published an updated scientific statement detailing the most salient barriers to successful transition—social determinants of health, impaired psychosocial functioning, and the high prevalence of neurocognitive deficits in this population—as well as specific considerations for the successful design and execution of a transition programme.2 As detailed in the 2022 AHA Scientific Statement, real-world programmes to empower patients in the transition process are needed. In their recent paper, EHJ-QCCO-D-22-00473R1 (Ricci et al.). Ricci et al. demonstrate a simple, externally reproducible process of achieving sustainable patient education and awareness of their CHD during the period of transition to adult care. This paper reflects a timely and innovative solution to address a recognized problem in the field. The programme utilized a service uniquely dedicated to transitioning care, with clinical nurses leading visits separated by an average of 16 months. Importantly, the programme built upon a foundation of standard medical discussions relating to the patients’ CHD by simply adding more pointed conversation addressing issues that are unique to transitioning to adulthood. Utilizing the Transition Service Assessment Questionnaire identified gaps in patient education, and served as a checklist of high-yield topics that would put patients at future risk. A clear example of the benefit of this service is in the improved patient understanding of the relationship between CHD and future pregnancy, a notable cause of maternal mortality that can be managed with adequate planning and preparation in patients with all but select forms of CHD.3 The service described by the authors demonstrated statistically significant improvements in the core understanding that patients had about their heart condition and its implications for their lives. Moreover, the checklist directly addressed topics such as work and education attainment that are directly impacted by a patient's heart condition but commonly left out of routine visits due to time constraints and competing demands. The results of this study highlight the effectiveness of the transition service for the majority of CHD patients—those with simple to moderate complexity diseases without significant physical or learning disabilities. While not surprising, the authors were able to demonstrate that a programme with relatively low resource utilization can improve transition for a wide range of the field. Moreover, an earlier introduction to the programme in a patient's course had a more impactful and sustainable effect. Even more impressive, the authors were able to pivot and adapt to the constraints of the COVID-19 pandemic, readily transitioning from in-person to virtual visits. As the threshold for communication between patients and medical teams is lowered in the virtual health era following the COVID-19 pandemic, this service can be implemented in the workflow of CHD centres. As virtual care becomes more readily incorporated into routine clinical care, further innovations may augment access to transitional care, especially given the near ubiquitous use of smartphones and other devices in patients in this age range. It is worth highlighting the negative findings of the study. Most importantly, the authors identified the subsets of patients least likely to improve their understanding of disease and benefit from their service—those with learning disabilities and more complex CHD. While this may be the minority of patients by volume, the most complex patients often have the highest morbidity, resource utilization, and inequity of care, as is the case with other chronic conditions. The authors described a successful step for the majority of patients, but highlighted the need for more wide-sweeping integrated care coordination to optimally serve patients of all severity and complexity of disease. Optimal care for patients with CHD across the field and within systems of care requires ownership and integration of care across the lifespan of the condition. CHD represents an integrated practice unit, in which multi-specialty stakeholders care for patients centred around a distinct condition across the cycle of that condition, from diagnosis through resolution or lifetime of the condition, both in times of acuity and chronicity.4 As healthcare becomes more interconnected and consolidated, designing care around integrated practice units can align outcomes between patients and care teams.5 The foundational step towards fully integrated care is measuring outcomes that are most important to patients and providers alike. While fundamental outcomes (mortality, complications, etc.) are routinely tracked, patient-generated outcomes that reflect the impact CHD has on their daily lives are not uniformly measured across our field. Outcomes such as quality of life, symptom liberation, social normalcy, perceived health status, depression/anxiety, work and school productivity, and financial burdens are measured primarily in small-scale academic studies, despite their relative importance in patients’ lives. Of late, collaboration of paediatric and adult CHD experts with patients, families, and patient advocacy groups have convened to create and disseminate the International Consortium of Health Outcomes Measurement Congenital Heart Disease Working Group standard set of outcomes in European Heart Journal Quality of Care and Clinical Outcomes.6 Incorporating both paediatric and adult patient-reported outcomes and risk-adjusted clinical metrics, frameworks such as this set create the opportunity to implement outcomes measurement in clinical practice across times of transition. Looking forward, aligning systems of care with such outcomes can drive change by (1) identifying and improving outcomes that matter to patients, (2) benchmarking across centres of care and a feedback loop for providers in each setting of the integrated care team, and (3) collaborating with payers to align and incentivize processes with such outcomes. The study by Ricci et al. outlines an effective service that begins to address these topics and can improve care for subsets of CHD patients. This programme serves as a microcosm for a larger movement to fully integrate care across the lifespan of CHD in order to drive high-value care and best serve patients. Conflict of interest: The authors declare no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Valle et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: